A test that costs less than a $1 and yields results in minutes has been shown in newly published studies to be more sensitive and more exact than the current standard test for early-stage prostate cancer.
The simple test developed by University of Central Florida scientist Qun “Treen” Huo holds the promise of earlier detection of one of the deadliest cancers among men. It would also reduce the number of unnecessary and invasive biopsies stemming from the less precise PSA test that’s now used.
“It’s fantastic,” said Dr. Inoel Rivera, a urologic oncologist at Florida Hospital Cancer Institute, which collaborated with Huo on the recent pilot studies. “It’s a simple test. It’s much better than the test we have right now, which is the PSA, and it’s cost-effective.”
When a cancerous tumor begins to develop, the body mobilizes to produce antibodies. Huo’s test detects that immune response using gold nanoparticles about 10,000 times smaller than a freckle.
When a few drops of blood serum from a finger prick are mixed with the gold nanoparticles, certain cancer biomarkers cling to the surface of the tiny particles, increasing their size and causing them to clump together.
Among researchers, gold nanoparticles are known for their extraordinary efficiency at absorbing and scattering light. Huo and her team at UCF’s NanoScience Technology Center developed a technique known as nanoparticle-enabled dynamic light scattering assay (NanoDLSay) to measure the size of the particles by analyzing the light they throw off. That size reveals whether a patient has prostate cancer and how advanced it may be.
And although it uses gold, the test is cheap. A small bottle of nanoparticles suspended in water costs about $250, and contains enough for about 2,500 tests.
“What’s different and unique about our technique is it’s a very simple process, and the material required for the test is less than $1,” Huo said. “And because it’s low-cost, we’re hoping most people can have this test in their doctor’s office. If we can catch this cancer in its early stages, the impact is going to be big.”
The Latest on: Prostate Cancer
via Google News
The Latest on: Prostate Cancer
- Dr. Song Announces Permanent & Safe Enlarged Prostate & Prostatitis Treatment at His Clinics in China on June 19, 2019 at 10:49 pm
and prostate cancer. Prostate patients can now head to China where Dr. Song offers a safe, permanent and non-surgical prostate treatment to cure various prostate diseases, including prostate cancer. ... […]
- Dr Song’s 3D Urology & Prostate Clinics Announces to Offer 3D Prostate Targeted Treatment to Cure Various Prostate Diseases on June 19, 2019 at 10:48 pm
enlarged prostates and prostate cancer. For all men suffering from prostate problems, reliable treatments are available at Dr. Song’s 3D Urology & Prostate Clinics in China. These clinics are equipped ... […]
- The most common cancer for men is still a mystery to science — but 9/11 first responders are giving researchers fresh clues on June 19, 2019 at 9:10 pm
Prostate cancer touches almost every American in some way. It is the most common form of cancer that men get, according to the National Cancer Institute, and it affects more than one in every five men ... […]
- VIDEO: TALAPRO-2 trial assesses talazoparib plus enzalutamide for metastatic prostate cancer on June 19, 2019 at 8:07 am
CHICAGO — Neeraj Agarwal, MD, professor of medicine and director of the genitourinary oncology program at The University of Utah’s Huntsman Cancer Institute, presented early safety results of the ... […]
- Research demonstrating the importance of exercise in cancer care on June 19, 2019 at 5:24 am
Research at Northumbria University, Newcastle is investigating the important role that structured exercise programmes can play in living with and beyond cancer. Cancers of the breast, prostate and ... […]
- Exploring subcellular responses of prostate cancer cells to X-ray exposure by Raman mapping on June 18, 2019 at 2:21 am
Understanding the response of cancer cells to ionising radiation is a crucial step in modern radiotherapy. Raman microspectroscopy, together with Partial Least Squares Regression (PLSR) analysis has ... […]
- With equal access to care, prostate cancer outcomes similar among black, white men on June 17, 2019 at 11:24 am
JAMA Oncol. 2019;doi:10.1001/jamaoncol.2019.0826. After controlling for nonbiological variations such as access to care and standardized treatment, black men with nonmetastatic prostate cancer had ... […]
- LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4 on June 17, 2019 at 4:40 am
Prostate cancer (PCa) is one of the major men malignancies worldwide. Long noncoding RNAs (lncRNAs) have been reported as essential regulators in human cancers, including PCa. In the present study, ... […]
- Prostate Cancer and Race on June 16, 2019 at 8:02 am
Over the years, as a staff medical reporter for a large metro daily in Chicago and a freelancer, I have written many stories about health issues affecting African Americans, including access to care, ... […]
- New drug helps men with advanced prostate cancer live longer on June 16, 2019 at 7:02 am
SALT LAKE CITY — A new medication helps men suffering from one of the deadliest forms of cancer live longer, a Huntsman Cancer Institute doctor said. Advanced prostate cancer is the second highest ... […]
via Bing News